Paul Edward Walker - Insider Trading & Ownership

Location
1954 Greenspring Drive, Suite 600, Timonium, MD
Summary
The estimated net worth of Paul Edward Walker is at least $364M dollars as of October 6, 2025. Paul Edward Walker is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146M. Paul Edward Walker is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $109M. Paul Edward Walker is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61.1M. Paul Edward Walker is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.6M. Paul Edward Walker is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $7.61M. Paul Edward Walker is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Paul Edward Walker is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $3.2K.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Paul Edward Walker

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146M Jun 28, 2021
SVRA Savara Inc 10%+ Owner $109M Jul 17, 2023
KRRO Korro Bio, Inc. 10%+ Owner $61.1M Apr 22, 2024
MBX MBX Biosciences, Inc. 10%+ Owner $38.6M Sep 16, 2024
TRVI Trevi Therapeutics, Inc. 10%+ Owner $7.61M Apr 11, 2022
MTCR Metacrine, Inc. 10%+ Owner $1.2M Dec 10, 2021
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $3.2K Jun 13, 2023
ALLK Allakos Inc. Director $0 May 15, 2025
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$26.4K -100% Oct 2, 2025
AKUS Akouos, Inc. 10%+ Owner Nov 30, 2022
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner May 24, 2022
TRIL Trillium Therapeutics Inc. Director Nov 17, 2021

Insider Transactions Reported by Paul Edward Walker:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.